WS-384 is a first-in-class inhibitor of LSD1 and DCN1-UBC12 protein–protein interaction, crucial in neddylation and subsequent ubiquitin-dependent protein proteasomal degradation, tested in NSCLC cells. Here, KDM1A is linked to non-small cell lung carcinoma.